MedTrace Logo

To Compare the Clinical Outcomes of FemtoLASIK and ICL Implantation in Treating Moderate Myopia Focusing on Refractive Stability, Contrast Sensitivity and High Order Aberrations.

NCT07291986 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-12-18

No results posted yet for this study

Summary

Compare the clinical outcomes of FemtoLASIK and ICL implantation in treating moderate myopia.

Conditions

  • Myopia, Moderate

Interventions

PROCEDURE

FemtoLASIK

FemtoLASIK surgery for simple and compound myopic patients

PROCEDURE

ICL implantation

ICL implantation for simple and compound myopic patients

Sponsors & Collaborators

  • Walid Osama Abdel Rahman Nour El Din

    lead OTHER

Principal Investigators

  • Omar M Said, MD · Faculty of Medicine, Fayoum University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-01
Primary Completion
2024-12-31
Completion
2025-05-06

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07291986 on ClinicalTrials.gov